Medindia

X

AMICAS Reinforces Market Leadership Position as Comprehensive Radiology IT Solutions Provider

Tuesday, September 11, 2007 General News J E 4
Advertisement
BOSTON, Sept. 10 AMICAS, Inc. (Nasdaq: AMCS), aleader in radiology and medical image and information management solutions,today announced that it has signed 3 contracts for its modern Vision SeriesFinancials product. In addition, AMICAS will display the full breadth of itsautomation solutions for radiology and billing practices at the RadiologyBusiness Management Association (RBMA) Fall Educational Conference fromSeptember 16 to 18 in Nashville, TN. AMICAS will be in booth # 301.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )

"We are thrilled to announce the signing of these 3 Vision SeriesFinancials contracts," said Paul Merrild, vice president of marketing atAMICAS. "We believe that the market is demonstrating an overwhelminglypositive response to our comprehensive radiology IT solutions. Our focus is onhelping our customers to grow, run, and optimize their practices -- and sincewe provide the complete solution for radiology practices, our customersexperience the best possible workflow."

AMICAS' full portfolio of imaging IT solutions -- including Vision SeriesFinancials -- will be on display at RBMA. These solutions include:

"We welcome our new Vision Series Financials customers and look forward toongoing partnerships with all of our customers as we work together torevolutionize radiology automation," said Mr. Merrild. "Because AMICASprovides the complete solution for radiology businesses - from PACS to RIS toFinancials to Document Management - our customers have a single IT partnershipthey can depend on. We will continue to invest in R&D and look forward toapplying our 30 years of experience to solving radiology's most challengingproblems."

AMICAS, Insight Dashboards, Insight Services, Vision Reach, and VisionSeries are trademarks or registered trademarks of AMICAS, Inc.

About AMICAS, Inc.

AMICAS, Inc. (http://www.amicas.com/) is a leader in radiology and medicalimage and information management solutions. The AMICAS(R) Vision Series(TM)products provide a complete, end-to-end solution for imaging centers,ambulatory care facilities, and radiology practices. Acute care and hospitalclients are provided with a fully integrated, hospital information system-independent PACS that features advanced enterprise workflow support andscalable design. Complementing the Vision Series product family is AMICASInsight(TM) Solutions, a set of client-centered professional and consultingservices that assist our customers with a well-planned transition to a digitalenterprise.

Safe Harbor Statement

Except for the historical information herein, the matters discussed inthis release include forward-looking statements. The forward-lookingstatements contained in this release include statements about present andfuture product and service availability, performance, and implementation. Whenused in this press release, the words: believes, intends, plans, anticipates,expects, estimates, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to a number ofrisks, assumptions, and uncertainties that could cause actual results todiffer materially as set forth in AMICAS' most recent filings with theSecurities and Exchange Commission. All forward-looking statements in thisrelease are qualified by these cautionary statements and are made only as ofthe date of this release.-- Vision Series Financials is a next generation radiology practice management and billing software system designed to meet the challenges of today's complex radiology billing environment. Vision Series Financials combines a modern architecture with pioneering functionality to streamline revenue cycle management needs. -- Insight Services is a suite of innovative revenue cycle management services designed to accelerate the time it takes to conve
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Specialists Are Turning to Biologics Earlier in th...
S
Baxter and Halozyme Announce Collaboration for Dev...